Sloan EK, Ciocca DR, Pouliot N, Natoli A, Restall C, Henderson MA, Fanelli MA, Cuello-Carrion FD, Gago FE, Anderson RL: Stromal Cell Expression of Caveolin-1 Predicts Outcome in Breast Cancer. Am J Pathol 2009, 174: 2035-2043
Ghajar CM, Meier R, Bissell MJ: Quis Custodiet Ipsos Custodies: Who Watches the Watchmen? Am J Pathol 2009, 174: 1996-1999
Novel Markers for Kidney Disease Progression
A group led by Drs. Erwin P. Bttinger of the Mount Sinai School of Medicine and Matthias Kretzler at the University of Michigan have established novel markers of kidney disease progression. Their report can be found in the June 2009 issue of the American Journal of Pathology.
Chronic kidney disease may affect up to 16.8% of the US population. Only a minority of patients with chronic kidney disease progress to end-stage renal disease. However, current clinical markers are not sufficient to reliably predict chronic kidney disease progression, which would allow for targeted treatment of high-risk patients.
To identify markers of chronic kidney disease progression, Ju et al screened a mouse model of progressive renal disease to identify genes whose expression correlated with renal disease severity. They then examined human versions of these genes, and found that a subset of these candidates were associated with disease progression and glomerular filtration rate in human patients.
The biomarkers identified by Dr. Bttinger, Dr. Kretzler, and colleagues "predict progressive renal fibrosis in mice and may [therefore] be useful molecular predictors of [chronic kidney disease] progression in humans."
Ju W, Eichinger F, Bitzer M, Oh J, McWeeney S, Berthier CC, Shedden K, Cohen CD, Henger A, Krick S, Kopp JB, Stoeckert Jr. CJ, Dikman S, Schrppel B, Thomas DB, Schlondorff D, Kretzler M, Bttinger EP: Renal Gene and Protein Expression Signatures for
|Contact: Angela Colmone|
American Journal of Pathology